Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Joe Biden at an October coronavirus briefing in Wilmington, Delaware, with participants including former Surgeon General Vivek Murthy and New York University professor Celine Grounder, who will serve on his advisory board. Photo: Drew Angerer/Getty Images

President-elect Joe Biden declared tackling the pandemic "one of the most important battles our administration will face" as he announced a new 12-member Transition COVID-19 Advisory Board on Monday.

Why it matters: The U.S. has reported over 100,000 new coronavirus cases every day since last Wednesday, when it first reached the milestone. The seven-day average of deaths from the virus reported by states has risen 36% in the past three weeks, per the COVID Tracking Project.

The big picture: COVID-19 is one of four key issues Biden has pledged to tackle on day one of his administration. The others are economic recovery, racial equity and climate change.

  • The task force will be led by three co-chairs: former Surgeon General Vivek Murthy, former Food and Drug Administration Commissioner David Kessler and Dr. Marcella Nunez-Smith from Yale University — as Axios' Hans Nichols first reported Saturday.
  • Beth Cameron, who served as senior director for global health security and biodefense in the Obama administration, and Rebecca Katz, co-director of the Center for Global Health Science and Security at Georgetown University, are advisors to the Transition on COVID-19 and will work closely with the advisory board.

Zoom in: Biden said in an emailed statement he wanted to be "informed by science and by experts," and there's a wealth of experience on the advisory board, which comprises:

Rick Bright, a vaccine expert, who resigned last month from a top Department of Health and Human Services position after alleging he was demoted for political reasons.

Eric Goosby, an infectious diseases expert who previously served in the Obama and Clinton administrations.

Luciana Borio, whose previous positions include Food and Drug Administration acting chief scientist.

Ezekiel Emanuel, an oncologist and adviser to Biden, who is vice provost for global initiatives at the University of Pennsylvania and who previously served in the Obama administration.

Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

Atul Gawande, a prominent doctor, health researcher and writer who served as a senior advisor in the Department of Health and Human Services in the Clinton administration.

Loyce Pace, president and executive director of the Global Health Council.

Julie Morita, executive vice president of the Robert Wood Johnson Foundation and former Chicago commissioner of health.

Celine Gounder, a clinical assistant professor of medicine and infectious diseases at New York University.

Robert Rodriguez, a professor of emergency medicine at the University of California, San Francisco, School of Medicine;

What they're saying: "The advisory board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations," Biden said.

  • The advisory board will help guide the Biden-Harris Transition in planning for the president-elect's federal response.
  • The advisers will "consult with state and local officials to determine the public health and economic steps necessary to get the virus under control, to deliver immediate relief to working families, to address ongoing racial and ethnic disparities, and to reopen our schools and businesses safely and effectively," the Biden transition team said in a statement.

Of note: Vice President Mike Pence was scheduled to reconvene a meeting on Monday afternoon with the White House Coronavirus Task Force, which has not met for weeks as he and President Trump campaigned for re-election.

Go deeper

Jan 29, 2021 - Health

J&J says its one-shot vaccine is 66% effective against moderate to severe COVID

Photo: Thiago Prudêncio/SOPA Images/LightRocket via Getty Images

Johnson & Johnson announced Friday that its single-shot coronavirus vaccine was 66% effective in protecting against moderate to severe COVID-19 disease in Phase 3 trials, which was comprised of nearly 44,000 participants across eight countries.

Between the lines: The vaccine was 72% effective in the U.S., but only 57% effective in South Africa, where a more contagious variant has been spreading. It prevented 85% of severe infections and 100% of hospitalizations and deaths, according to the company.

Jan 29, 2021 - Health

WHO says most pregnant women can now receive coronavirus vaccine

A doctor administering Moderna's coronavirus vaccine at a university hospital in Essen, Germany, on Jan. 18. Photo: Lukas Schulze/Getty Images

The World Health Organization has altered its guidance for pregnant women who wish to receive the coronavirus vaccine, saying now that those at high risk of exposure to the COVID-19 or who have comorbidities that increase their risk of severe disease, may be vaccinated.

Why it matters: The WHO drew backlash for its previous guidance that did not recommend pregnant women be inoculated with vaccines made by Pfizer-BioNTech or Moderna, even though data indicated that pregnancy increased the risk of developing severe illness from the virus.